Denali Therapeutics, Inc. (DNLI)
21.20
-0.20
(-0.93%)
USD |
NASDAQ |
Sep 11, 15:43
Denali Therapeutics Gross Profit (TTM) : -11.46M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.46M |
| March 31, 2026 | -12.62M |
| December 31, 2025 | -12.10M |
| September 30, 2025 | -10.17M |
| June 30, 2025 | -9.061M |
| March 31, 2025 | -7.958M |
| December 31, 2024 | -7.795M |
| September 30, 2024 | -8.119M |
| June 30, 2024 | -7.231M |
| March 31, 2024 | 287.48M |
| December 31, 2023 | 315.61M |
| September 30, 2023 | 324.84M |
| June 30, 2023 | 328.08M |
| March 31, 2023 | 86.56M |
| December 31, 2022 | 101.43M |
| September 30, 2022 | 105.58M |
| June 30, 2022 | 103.30M |
| March 31, 2022 | 52.05M |
| December 31, 2021 | 11.20M |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 123.30M |
| June 30, 2019 | 122.16M |
| March 31, 2019 | 122.32M |
| December 31, 2018 | 122.10M |
| September 30, 2018 | -2.001M |
| June 30, 2018 | -1.647M |
| March 31, 2018 | -1.798M |
| December 31, 2017 | -1.585M |
| September 30, 2017 | -1.464M |
| June 30, 2017 | -1.087M |
| March 31, 2017 | -1.087M |
| December 31, 2016 | -1.087M |
| September 30, 2016 | -0.401M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |